Genomic Health is a global healthcare company that provides actionable genomic information to personalize cancer treatment decisions.
Genomic Health is a global healthcare company that provides actionable genomic information to personalize cancer treatment decisions. Genomic Health has a robust pipeline focused on developing tests to optimize the treatment of renal cell cancers, as well as additional treatment decisions in breast and colon cancers. The company is based in Redwood City, California with European headquarters in Geneva, Switzerland.
To learn more about Oncotype DX tests, visit: www.OncotypeDX.com and www.mybreastcancertreatment.org and www.myprostatecancertreatment.org.
Genomic Health is dedicated to transforming treatment decisions and outcomes in cancer by delivering clinically actionable diagnostics and services for patients.
Every cancer is unique and affects each diagnosed person differently based on the biology of their disease. To address this diversity and make cancer care smarter at every stage, our Oncotype IQ portfolio of diagnostic tests and services delivers clinically relevant genomic intelligence that reveals the individual biology of a patient's tumor. This genomic insight helps physicians optimize treatment decisions for breast, colon, and prostate cancers. For more information, please visit www.OncotypeIQ.com.
